# HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial

> **NCT04653818** · PHASE4 · COMPLETED · sponsor: **Alexandria University** · enrollment: 84 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Hepatitis C
- Neoplasm Recurrence
- Treatment Complication

## Interventions

- **DRUG:** Velpatasvir/Sofosbuvir

## Key facts

- **NCT ID:** NCT04653818
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-05
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-10-24
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04653818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04653818, "HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04653818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*